Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00600795 · ClinicalTrials.gov registry record
Prognostic Value of Transforming Growth Factor-Beta 1 in Normal Pressure Hydrocephalus
A clinical trial of Normal Pressure Hydrocephalus, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 21
- Enrollment target
- 1
- Study location
NCT00600795 is a study of Normal Pressure Hydrocephalus that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 21 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00600795, a study of Normal Pressure Hydrocephalus, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
Correlation of cerebrospinal fluid levels of transforming growth factor beta-1 with functional improvements after insertion of ventriculoperitoneal shunt for normal pressure hydrocephalus
Conditions Studied
Interventions
- OTHER CSF collection
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2008-01 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00600795
The ClinicalTrials.gov registry entry for NCT00600795 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Normal Pressure Hydrocephalus appearing as the primary indexed condition, and to 1 intervention - of which CSF collection is the first listed.
NCT00600795 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00600795 about?
NCT00600795 is a clinical study titled "Prognostic Value of Transforming Growth Factor-Beta 1 in Normal Pressure Hydrocephalus". Correlation of cerebrospinal fluid levels of transforming growth factor beta-1 with functional improvements after insertion of ventriculoperitoneal shunt for normal pressure hydrocephalus
What is the current status of trial NCT00600795?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2008-01. Estimated completion is 2011-06.
What conditions does trial NCT00600795 study?
This clinical trial studies the following conditions: Normal Pressure Hydrocephalus.
What interventions are being tested in trial NCT00600795?
The interventions under investigation include: CSF collection (OTHER).
Who is sponsoring clinical trial NCT00600795?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00600795 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Normal Pressure Hydrocephalus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.